Kliničke studije za Rak pluća u državi Kansas
21 studija za Rak pluća traži sudionike na lokacijama u državi Kansas.
Gradovi u državi Kansas
- Overland Park11 studija
- Kansas City11 studija
- Olathe6 studija
- Topeka6 studija
- Wichita5 studija
- Salina5 studija
- Lawrence5 studija
- Hays4 studija
Službeni tekst studije (engleski)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- The University of Kansas Cancer Center - Olathe, Olathe
- Cancer Center of Kansas - Pratt, Pratt
- Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04267848Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- i još 4
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita
- Ascension Via Christi Hospitals Wichita, Wichita
- Cancer Center of Kansas - Wichita, Wichita
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT04181060Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06498635Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- The University of Kansas Cancer Center, Westwood
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT06881784This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Saint Luke's South Hospital, Overland Park
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06758401Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- i još 1
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT06287775A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The University of Kansas Cancer Center - Westwood, Westwood
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06119581Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06343402Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT06500481Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- University of Kansas Cancer Center, Kansas City
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- i još 5
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT05624996A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Kansas Cancer Center, Kansas City
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT05592626Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- The University of Kansas Cancer Center, Westwood
U tijeku regrutacijaFaza 1/2
Od 18 do 70 godina · Oba spola · Ažurirano 11. lip 2026. · NCT05361174Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- i još 7
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 3. lip 2026. · NCT05642572Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- i još 7
U tijeku regrutacijaFaza 2
18 Minutes · Oba spola · Ažurirano 5. svi 2026. · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- i još 8
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 5. svi 2026. · NCT06616584A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- The University of Kansas Cancer Center, Fairway
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 18. ožu 2026. · NCT06244771Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Aton Health, Leawood
- Ascension Via Christi Wichita, Wichita
U tijeku regrutacijaOpažajna studija
Od 50 godina i više · Oba spola · Ažurirano 5. kol 2025. · NCT06122077Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaOpažajna studija
Od 29 do 85 godina · Oba spola · Ažurirano 13. stu 2024. · NCT06426628Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
- The University of Kansas Cancer Center (KUCC), Fairway
- The University of Kansas Cancer Center, Westwood Campus, Kansas City
U tijeku regrutacijaOpažajna studija
Od 18 do 110 godina · Oba spola · Ažurirano 23. velj 2024. · NCT05332925Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.